Bacteriological Study of Pathogenic Staphylococci with Special Reference to Vancomycin Susceptibility
Subscribe/Renew Journal
Background: Staphylococci are one of the most frequently isolated organisms in microbiology laboratory from a variety of clinical specimens. Invasive Staphylococcal disease had mortality rate of about 90%, before the advent of wonder drug Penicillin in 1940. How ever in 1942, resistance was described and by 1960's resistance to semi synthetic penicillins like Methicillin & Oxacillin was observed. Methicillin-resistant Staphylococcus aureus resistant to all antibiotics including Vancomycin has been reported in Japan, USA, Canada and Brazil. Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant Staphylococcus Aureus (MRSA). The emergence of Vancomycin Intermediate and Resistant Staphylococcus aureus (VISA and VRSA, respectively) in various parts of the world has been of great concern in clinical settings.
Objective: This study was performed to evaluate the possible presence of VISA and VRSA at Andhra Medical College, Visakhapatnam.
Method: The present study was conducted in the Department of Microbiology. MRSA strains were tested for Vancomycin susceptibility by standard Kirby-Bauer disc diffusion method, agar dilution method and by E-test according to standards of NCCLS
Results & Conclusions: Using disk diffusion test, most isolates were resistant to penicillin, while three of the isolates had Vancomycin MIC of 8 g/ml. All the 3 VISA strains showed multi drug resistance indicating the need to create awareness regarding these strains in the local scenario.
Keywords
- CDC. National Nosocomial Infections Surveillance report, data summary from October 1986-April 1996, issued May 1996. Am J Infect Control 1996; 24: 380-8.
- Harold C. N., Anti Staphylococcal Penicillins, the Medical Clinics of North America, Jan 1982; 66(1):51-60.
- Barber Mary., Methicillin resistant staphylococci, Journal of Clinical Pathology, Feb 1961; 14:385- 393.
- Bary D., Cookson., Staphylococcus aureus principles and practices of Clinical Bacteriology, Edited by Emerson A.M., Hawkey P.M., Gillespie S.H.,1997;109-129.
- Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520 – 32.
- Milligan M. E. et.al, Methicillin-resistant Staphylococcus aureus; A consensus review of the Microbiology, pathogenesis and epidemiology with implication for prevention and management, American Journal of Medicine, March 1993;94: 313-324
- Hiramatsu K, Hanaki H, Ino T, Methicillinresistant Staphylococcus aureus clinical strain with reduced Vancomycin susceptibility. J Anti microb.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved standard, M7-A6. Wayne, Pennsylvania; 2003.
- CDC Hageman JC, Patel JB, Carey RC, Tenover FC.Investigetion and control of Vancomycin – intermediate and resistant Staphylococcus aureus. A Guide for Health Departments and Infection Control Personnel.Atlanta GA2006 pg 5.
- Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev 2002; 15: 430–8.
- Orrett F.A., Land M., Methicillin resistant Staphylococcus aureus prevalence: current susceptibility patterns in Trinidad, BMC Infectious Diseases, 2006 May 5; 6:83.
- Hakim S T, Arshed S, Iqbal M, Javaid S.G., Vancomycin sensitivity of Staphylococcus aureus isolates from hospital patients in Karachi, PAKISTAN, Libyan Journal of Medicine, 18th July 2007.
- Anupurba S., Sen M.R., Nath G., Sharma B.M., Gulati A.K., Mohapatra T. M., Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian Journal of Medical Microbiology, 2003; 21: 49-51.
- Bhateja P, Mathur T, Pandya M, Fatma T, Rattan Ashok, detection of Vancomycin resistant Staphylococcus aureus, Indian Journal of Medical Microbiology, 2005; 23(1): 52-55.
- Mallaval F.O., Carricajo A, Delavenna F, Recule C, Fonsale N, Manquat G, Raffenot D, Rogeaux O, Aubert G, Tous J, Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital, Clinical Microbiology Infections, 2004 May; 10(5):459-61.
- Yasmin Maor, Galia Rahav, Natasha Belausov, Debby Ben-David, Gill Smollan, and Nathan Keller, Prevalence and Characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus Bacteremia in a Tertiary Care Center Infectious Disease Unit/ Microbiology Laboratory, Tel Aviv University, Sheba Medical Center, Tel Hashomer, Israel.
Abstract Views: 306
PDF Views: 0